1986
DOI: 10.1159/000206020
|View full text |Cite
|
Sign up to set email alerts
|

Missing Y Chromosome in 2 Patients with Chronic Myelocytic Leukemia

Abstract: 2 cases of chronic myelocytic leukemia (CML) without Y chromosome are reported. One is a 45-year-old man with Philadelphia-positive CML, and the other a 74-year-old patient with Philadelphia-negative CML. Cytogenetic analysis of bone marrow and peripheral blood cultures with and without PHA stimulation was carried out. The Philadelphia-positive patient died after 15 months, whereas in the case of the Philadelphia-negative patient, the survival time of 27 months exceeded the median survival time usually reporte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1988
1988
1991
1991

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…The missing Y chromosome associated with Phi-negative CML has been reported quite rarely [4][5][6], although a significant proportion (6-8%) of CML patients show no Phi chromosome [11,12]. Re cently, great advances in investigating the molecular and biologic pathogenesis of CML have been made.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The missing Y chromosome associated with Phi-negative CML has been reported quite rarely [4][5][6], although a significant proportion (6-8%) of CML patients show no Phi chromosome [11,12]. Re cently, great advances in investigating the molecular and biologic pathogenesis of CML have been made.…”
Section: Discussionmentioning
confidence: 99%
“…Although male patients with Philadelphia chromo some (Phl)-positive chronic myeloid leukemia (CML) sometimes show a loss of the Y chromosome [1][2][3], only a few cases of Phi-negative CML with missing Y chromosome as the sole abnormality have been reported [4][5][6]. These cases seem to be indis tinguishable clinically and hematologically from Phi-positive CML, but they show no evidence whether their molecular events are the same as those in Ph 1 -positive CML.…”
Section: Introductionmentioning
confidence: 99%